Related Experiment Video

Updated: Aug 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new

Gema Ariceta1, Ellen R Brooks, Craig B Langman

  • 1Division of Kidney Diseases, Children's Memorial Hospital, Chicago, IL 60614, USA. g-ariceta@northwestern.edu

Pediatric Nephrology (Berlin, Germany)
|August 6, 2005
PubMed

Insights

Elevated B-type natriuretic peptide (BNP) levels indicate heart problems in adults and predict cardiovascular events. Further research is needed to understand BNP

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Elevated B-type natriuretic peptide (BNP) is linked to left ventricular (LV) dysfunction.
  • BNP is a sensitive diagnostic and prognostic marker for cardiovascular (CV) events in adults, including those with hypertension and chronic kidney disease (CKD).
  • BNP levels can be affected by age and renal function, requiring careful interpretation.

Purpose of the Study:

  • To explore the potential application of plasma BNP measurements in pediatric patients with CKD.
  • To investigate BNP as a biomarker for cardiovascular disease in children with CKD.

Main Methods:

  • Literature review on BNP's role in adult cardiovascular disease.
  • Analysis of existing data regarding BNP levels in children, particularly those with congenital heart disease.
  • Assessment of the relevance of BNP in pediatric CKD populations.

Main Results:

  • BNP is a well-established marker for cardiovascular disease and events in adults.
  • Data on BNP in children are scarce, primarily focusing on congenital heart disease.
  • CKD is a significant risk factor for cardiovascular disease in children.

Conclusions:

  • BNP shows promise as a biomarker for cardiovascular risk in children with CKD.
  • Further studies are warranted to validate BNP's utility in pediatric CKD.
  • Understanding BNP in pediatric CKD may improve cardiovascular risk assessment and management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...